Key Points
BENGALURU (Reuters) -Dabur India said on Wednesday a U.S. court had dismissed two of its three subsidiaries as defendants in a lawsuit tying the use of hair relaxer products to ovarian and uterine cancers as well as other health issues...
Dermoviva Skin Essentials and Dabur International have been dismissed as defendants for lack of personal jurisdiction as neither was involved in manufacturing, marketing, distributing or selling hair relaxer products in the United States, the company said in a late filing on Wednesday...
However, Daburs unit Namaste Laboratories continues to be a defendant along with many other industry players such as LOreal , Revlon, Luster Products and Avion Industries among others, it added...
About 5,400 cases against several companies, including Daburs subsidiaries, were consolidated in multi-district litigation before a U.S. District Court in Illinois, Dabur said last month, after thousands of women, mostly Black women, claimed hair relaxers gave them cancer...
Sales of hair relaxer products by Namaste account for less than 1% of the total consolidated turnover of Dabur India, the parent company said, adding that neither does the lawsuit concern any of its brands nor is Dabur a party to it...
You might be interested in
Dabur subsidiaries sued in US, Canada over allegations of its products causing cancer
19, Oct, 23Dabur sued in US, Canada: Dabur has denied liability and said that these allegations are based on “unsubstantiated and incomplete study”.
Two Dabur India's subsidiaries get clearance in US litigation, Namaste Labs to face charges
16, Nov, 23Dabur has clarified that the lawsuit doesn't pertain to any Dabur brand or product, emphasising that Dabur India Ltd is not a party to these suits.